Alvotech Files July 2025 Report on Form 6-K

Ticker: ALVOW · Form: 6-K · Filed: Jul 1, 2025 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateJul 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, biotech

TL;DR

Alvotech filed its monthly 6-K report with the SEC on July 1, 2025.

AI Summary

Alvotech, a biopharmaceutical company, filed a Form 6-K on July 1, 2025, to report its activities for the month of July 2025. The company is incorporated in Luxembourg and operates in the biological products sector. This filing is made under the Securities Exchange Act of 1934.

Why It Matters

This filing provides routine updates from Alvotech, a foreign private issuer, to the SEC, informing investors about ongoing company activities and compliance.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or strategic information.

Key Numbers

  • 001-41421 — SEC File Number (Identifies Alvotech's filing with the SEC.)
  • 20250701 — Filing Date (Date Alvotech submitted this Form 6-K.)

Key Players & Entities

  • Alvotech (company) — Registrant
  • 001-41421 (company) — SEC File Number
  • 2836 (company) — Standard Industrial Classification Code
  • Alvotech Lux Holdings S.A.S. (company) — Former Company Name

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with any stock exchange, or that they have distributed or are required to distribute to their security holders.

What is Alvotech's primary business sector?

Alvotech operates in the Biological Products (No Diagnostic Substances) sector, with a Standard Industrial Classification code of 2836.

When was Alvotech's name previously changed?

Alvotech's former company name was Alvotech Lux Holdings S.A.S., and the date of the name change was December 9, 2021.

Where is Alvotech's principal executive office located?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

Does Alvotech file annual reports under Form 20-F?

Yes, Alvotech indicates it files annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding Alvotech (ALVOW).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.